The 16-electron transition metal amide complexes, Cp*M[κ 2 ( N,N ‘ ) - ( S,S )-TsNCHPhCHPhNH] (M = Ir, Rh, Cp* = pentamethylcyclopentadienyl, Ts = p -toluenesulfonyl, Ph = C 6 H 5 ) and Ru[κ 2 ( N,N ‘ ) - ( S,S )-TsNCHPhCHPhNH]( p -cymene), react with acidic alcohols, CF 3 CH 2 OH or phenols, to give the corresponding alkoxide complexes, which are readily convertible to metallacycles via intramolecular C−H bond activation of the aromatic group on the diamine ligand. For example, the Ir and Rh amide complexes are transformed to the metallacycles Cp*M[κ 3 ( N,N ‘,C )-( S,S )-CH 3 C 6 H 3 SO 2 NCHPhCHPhNH 2 ] (M = Ir, Rh), while the Ru amide complex having structures isoelectronic with the Cp*Ir complex gives two types of metallacycles, Ru[κ 3 ( N,N ‘,C ) - ( S,S )-CH 3 C 6 H 3 SO 2 NCHPhCHPhNH 2 ]( p -cymene) and Ru[κ 3 ( N,N ‘,C ) - ( S,S )-TsNCHPhCH(C 6 H 4 )NH 2 ]( p -cymene), which are formed by the C−H bond activation of an aromatic ring in either the Ts group or the diamine ligand. NMR study for the cyclometalation of the Ir amide complex with phenols suggests that the reaction proceeds through the phenoxide complexes as intermediates.
No takes yet. Share an insight, caveat, or question.
Koike et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: